Jiangsu Hengrui Medicine
600276.SS
#504
Rank
A$64.62 B
Marketcap
$10.13
Share price
0.39%
Change (1 day)
5.55%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total debt

Total debt on the balance sheet as of September 2024 : A$19.75 Million

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total debt is A$19.75 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Jiangsu Hengrui Medicine - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2022-12-31A$0.28 B782.94%
2021-12-31A$32.81 M
2015-12-31A$2.12 M7.65%
2014-12-31A$1.97 M-46.74%
2013-12-31A$3.7 M140.06%
2012-12-31A$1.54 M-50.27%
2011-12-31A$3.1 M4.23%
2010-12-31A$2.97 M82.71%
2009-12-31A$1.62 M
2007-12-31A$9.4 M20.62%
2006-12-31A$7.8 M-4.06%
2005-12-31A$8.13 M-47.46%
2004-12-31A$15.47 M-74.98%
2003-12-31A$61.85 M12.45%
2002-12-31A$55 M-7.77%
2001-12-31A$59.63 M51.07%
2000-12-31A$39.47 M6.1%
1999-12-31A$37.2 M34.37%
1998-12-31A$27.68 M17.29%
1997-12-31A$23.6 M